← All Articles

Private Company Valuation: Valuing Non-Listed Companies Using Damodaran

What you'll take away from this article
  • Avoidable mistakes: Total Beta — the right risk measure
  • Key-Person Discount — explained practically for your portfolio
  • Illiquidity discount — concrete recommendations

Listed companies have a market price. Private ones do not. This changes the valuation logic: no Market Beta, no liquidity premium, and the key-person risk can reduce value by 15-25%. Professor Damodaran (NYU Stern) developed the standard methodology.

Total Beta: The Right Risk Measure

Standard Beta only measures systematic risk. For non-diversified owners, you need Total Beta: Total Beta = Market Beta / Correlation with Market. Example: Beta 1.18 / Correlation 0.5 = Total Beta 2.36. Cost of Equity rises from ~10% to ~14.5%.

Key-Person Discount

In many SMEs, 50-80% of revenue depends on the founder. Key-Person Discount: typically 15-25%. Factors to consider: revenue concentration, customer relationships (personal vs. institutional), process documentation.

What this means for you

When you apply this knowledge, you gain a concrete advantage over competitors who enter investor conversations without this foundation. Use the insights from this article as the basis for your next step.

Illiquidity Discount

15-35% depending on the study. Damodaran recommends: apply the discount EITHER to the discount rate OR to enterprise value — never both. The discount varies by buyer type: Private-to-Private (highest), Private-to-Public (moderate), IPO (lowest).

Our Capital Intelligence considers all characteristics of private companies.

Further reading: 3 Valuation Methods · DCF Valuation · EBITDA Multiple

Your advantage after this article

What you now know — and how to use it

  • You know the core concepts and can apply them directly to your situation
  • You know which mistakes to avoid — saving you time and capital
  • You understand how this building block fits into your overall strategy

Your next step: Have your situation professionally assessed — free and non-binding in an initial consultation with Daniel Huber.

Daniel Huber
Daniel Huber Founder & CEO, CANVENA
Daniel Huber

Ready for the next step?

In 30 minutes, Daniel Huber shows you which capital strategy fits your situation.

Found this useful? Add Canvena as a preferred source on Google - our analyses will then be highlighted in your Search and AI results.

Add Canvena as a preferred source